** Shares of Compumedics CMP.AX rise 12.3% to A$0.32, hitting their highest level since Oct. 17
** Medical diagnostics firm expects sales of more than A$55 million ($34.02 million) for fiscal 2025, up from A$52 mln a year ago
** Co also logged sales orders of A$32.8 mln in 1H25 vs A$30.3 mln in 1H24
** Attributes higher sales to U.S. "continuing to provide evidence of accelerating sales growth;" added U.S. orders were up 208% in 1H25 compared to last year
** Stock eyeing its best trading session since early September, if current gains hold
** More than 102,000 shares change hands, 2.4 times the 30-day avg
** Compumedics up 20.8% YTD, including current session's moves
($1 = 1.6166 Australian dollars)
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。